 |
 |
 |
For Market’s Latest Update Join Us on Telegram
 |
Nephrocare Health IPO GMP
Nephrocare Health IPO is a Mainboard IPO, the company will raise up to 1,89,35,819 shares (Aggregating up to ₹871.05 crore) via this IPO. The IPO comprises a fresh issue of 76,82,717 shares (Aggregating up to ₹353.40 crore), and an offer for sale (OFS) of shares (amount) 1,12,53,102 shares (Aggregating up to ₹517.64 crore).
Nephrocare Health IPO will open for subscription on 10 December 2025 and close on 12 December 2025. Basis of allotment will be decided on 15 December 2025, initiation of refund will begin on 16 December 2025 and finally IPO will be listed on 17 December 2025 at NSE, BSE. Ambit Pvt Ltd, ICICI Securities Ltd, IIFL Capital Services Ltd and Nomura Financial Advisory & Securities (India) Pvt Ltd is the book running lead manager and Kfin Technologies Ltd is the registrar of the Nephrocare Health IPO.
Total shares offered by Nephrocare Health IPO is 1,89,35,819 shares (Aggregating up to ₹871.05 crore). Out of which Not less than 35% of the net offer is reserved for retail, Not less than 15% of the net offer is reserved for HNI (NII), Not more than 50% of the net offer is reserved for QIB.
Nephrocare Health IPO Price Band and Market Lot
Nephrocare Health has set a price band of ₹438 to ₹460 per share and lot size is of 32 shares. Retail investors can bid for a minimum of 1 lots (32 shares), requiring minimum investment of ₹14,720, and maximun upto 13 lots (416 shares), requiring maximum investment of ₹1,91,360. Small HNI investors can bid for a minimum of 14 lots (448 shares), requiring an investment of ₹2,06,080, small hni (shni) investors can bid for a maximum of 67 lots (2,144 shares), requiring an investment of ₹9,86,240 and big hni (bHNI) investors can bid for a minimum of 68 Lots (2,176 shares), requiring an investment of ₹10,00,960. Calculated at the cut-off price ₹460 per share (the upper end of the price band).
Nephrocare Health IPO Subscription Status Today (Live)
Currently there is no any subscription data available for Nephrocare Health IPO. Nephrocare Health IPO subscription Status data will be available on 10 December 2025 because IPO will open for subscription on 10 December 2025 and close on 12 December 2025.Nephrocare Health IPO GMP (Grey Market Premium) Today (Live)
Visit us daily to get the latest update on Nephrocare Health IPO GMP. Nephrocare Health IPO GMP started, and here you can get the latest update of Nephrocare Health IPO GMP.
Nephrocare Health IPO GMP today or grey market premium, and the Latest GMP Data pattern is available here.
- Price Band of Nephrocare Health IPO is ₹438 to ₹460 per share.
- Current GMP (Grey Market Premium) for Nephrocare Health IPO is:
- It is a premium for the Nephrocare Health IPO cut-off price ₹460 per share.
- As per Nephrocare Health IPO Taday’s GMP Data, the estimated listing price of Nephrocare Health IPO shares can be:
- Estimated listing price calculated as Nephrocare Health IPO cutoff price or allotment price: ₹460 per share + IPO current GMP: .
| Nephrocare Health Services IPO GMP | ||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 0 | |
| 7 December 2025 | 0 | |
| 6 December 2025 | 0 | |
| 5 December 2025 | 0 | |
| 4 December 2025 | 0 | |
| 30 Sep 25 in crore | 31 Mar 2025 in crore | 31 Mar 24 in crore | 31 Mar 23 in crore | |
|---|---|---|---|---|
| Assets | 1,193.68 | 996.46 | 806.02 | 666.23 |
| Revenue | 483.97 | 769.92 | 574.72 | 443.26 |
| Profit After Tax | 14.23 | 67.1 | 35.13 | -11.79 |
| EBITDA | 110.31 | 166.64 | 99.66 | 48.6 |
| Net Worth | 716.06 | 594.21 | 423.55 | 384.73 |
| Total Borrowing | 207.04 | 225.8 | 243.37 | 196.21 |
| Reserves & Surplus | 704.14 | 578.68 | 408.57 | 383.5 |
| Nephrocare Health IPO Time Table (Tentative) | |
| IPO Open Date | 10 December 2025 |
| IPO Close Date | 12 December 2025 |
| Basis of Allotment Date | 15 December 2025 |
| Initiation of Refunds | 16 December 2025 |
| Credit of Share to Demat Account | 16 December 2025 |
| IPO Listing Date | 17 December 2025 |
| IPO Cut-off time (UPI mandate confirmation) | 5:00 PM on 12 December 2025 |
| Nephrocare Health IPO Reservation | |
| Retail Quota | Not less than 35% of the net offer |
| NII Quota | Not less than 15% of the net offer |
| QIB Quota | Not more than 50% of the net offer |
| Total | 1,89,35,819 shares (100.00%) |
| Nephrocare Health IPO Price | |
| Face Value | ₹2 per share |
| Price Band | ₹438 to ₹460 per share |
| Lot Size | 32 shares |
| IPO Issue Type | Book Built Issue |
About Nephrocare Health (Company Overview)
Nephrocare Health Services Limited founded in 2009 and headquartered in Hyderabad, is a leading Indian specialty healthcare company focused on providing dialysis and comprehensive renal care services through a large network of dedicated kidney care centres. The company operates under the “NephroPlus” brand and has grown into one of Asia’s largest dialysis providers by treatment volumes.
Nephrocare Health’s network spans hundreds of clinics across multiple states of India and union territories, serving tens of thousands of chronic kidney disease patients on a recurring basis. The company also has international presence such as the Philippines, Uzbekistan, Nepal and Saudi Arabia. It reflects company’s ambition to build a scalable, pan‑regional renal care platform.
The company offers a full suite of dialysis modalities including in clinic haemodialysis, home haemodialysis, hemodiafiltration, holiday dialysis for travelling patients, and mobile or on call dialysis services designed to improve access and continuity of care. Its model combines standalone dialysis centres with in‑hospital units set up in partnership with leading hospitals, enabling wide geographic reach across metros, tier‑2 and tier‑3 cities.
Nephrocare Health IPO Frequently Asked Questions
The latest Grey Market Premium (GMP) of Nephrocare Health IPO is .
It is a premium to the IPO cut-off price Nephrocare Health. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Nephrocare Health IPO can be .
Expected listing listing price for Nephrocare Health share can be .
According to latest GMP data pattern expected listing price and profit per share for Nephrocare Health IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider Nephrocare Health fundamentals and your risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for Nephrocare Health IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell Nephrocare Health IPO forms in the grey market and GMP prices shown here are gathered from various sources.